Literature DB >> 16633135

Probiotics and chronic disease.

Ilse J Broekaert1, W Allan Walker.   

Abstract

In today's climate, changed lifestyles and the increased use of antibiotics are significant factors that affect the preservation of a healthy intestinal microflora. The concept of probiotics is to restore and maintain a microflora advantageous to the human body. Probiotics are found in a number of fermented dairy products, infant formula, and dietary supplements. Basic research on probiotics has suggested several modes of action beneficial for the human body and clinical research has proven its preventive and curative features in different intestinal and extraintestinal diseases. Chronic diseases cause considerable disablement in patients and represent a substantial economic burden on healthcare resources. Research has demonstrated a crucial role of nutrition in the prevention of chronic disease. Thus, positive, strain-specific effects of probiotics have been shown in diarrheal diseases, inflammatory bowel diseases, irritable bowel syndrome, and Helicobacter pylori-induced gastritis, and in atopic diseases and in the prevention of cancer. As the majority of probiotics naturally inhabit the human intestinal microflora, their use has been regarded as very safe. However, in view of the range of potential benefits on health that might be achieved by the use of some probiotic bacteria, major and thorough evaluation is still necessary. In conclusion, probiotics act as an adjuvant in the prevention and treatment of a wide variety of chronic diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16633135     DOI: 10.1097/00004836-200603000-00021

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  Perceptions of medical sciences students towards probiotics.

Authors:  Laleh Payahoo; Zeinab Nikniaz; Reza Mahdavi; Mohamad Asghari Jafar Abadi
Journal:  Health Promot Perspect       Date:  2012-07-01

2.  Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa.

Authors:  Sandra Voltan; Ignazio Castagliuolo; Marina Elli; Stefano Longo; Paola Brun; Renata D'Incà; Andrea Porzionato; Veronica Macchi; Giorgio Palù; Giacomo C Sturniolo; Lorenzo Morelli; Diego Martines
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

3.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

4.  The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal.

Authors:  Melinda A Engevik; Heather A Danhof; Anne Hall; Kristen A Engevik; Thomas D Horvath; Sigmund J Haidacher; Kathleen M Hoch; Bradley T Endres; Meghna Bajaj; Kevin W Garey; Robert A Britton; Jennifer K Spinler; Anthony M Haag; James Versalovic
Journal:  BMC Microbiol       Date:  2021-05-24       Impact factor: 3.605

5.  Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis.

Authors:  Manuel Oliveira; Nabil Bosco; Genevieve Perruisseau; Jeanne Nicolas; Iris Segura-Roggero; Stéphane Duboux; Muriel Briand; Stéphanie Blum; Jalil Benyacoub
Journal:  Clin Dev Immunol       Date:  2011-07-25

6.  Bifidobacteria strains isolated from stools of iron deficient infants can efficiently sequester iron.

Authors:  Pamela Vazquez-Gutierrez; Christophe Lacroix; Tanja Jaeggi; Christophe Zeder; Michael Bruce Zimmerman; Christophe Chassard
Journal:  BMC Microbiol       Date:  2015-01-16       Impact factor: 3.605

Review 7.  Probiotics reduce mutans streptococci counts in humans: a systematic review and meta-analysis.

Authors:  Isabelle Laleman; Valentine Detailleur; Dagmar Else Slot; Vera Slomka; Marc Quirynen; Wim Teughels
Journal:  Clin Oral Investig       Date:  2014-03-25       Impact factor: 3.573

8.  The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012.

Authors:  Chao-Hung Kuo; Fu-Chen Kuo; Huang-Ming Hu; Chung-Jung Liu; Sophie S W Wang; Yen-Hsu Chen; Ming-Chia Hsieh; Ming-Feng Hou; Deng-Chyang Wu
Journal:  Gastroenterol Res Pract       Date:  2012-06-27       Impact factor: 2.260

9.  Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study.

Authors:  Wim Teughels; Andaç Durukan; Onur Ozcelik; Martine Pauwels; Marc Quirynen; Mehmet Cenk Haytac
Journal:  J Clin Periodontol       Date:  2013-09-15       Impact factor: 8.728

10.  A comparative evaluation of the efficacy of probiotic and chlorhexidine mouthrinses on clinical inflammatory parameters of gingivitis: A randomized controlled clinical study.

Authors:  Purnima Vidyesh Nadkerny; Potluri Leela Ravishankar; Virupapuram Pramod; Lavanya Abhay Agarwal; Saurabh Bhandari
Journal:  J Indian Soc Periodontol       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.